AI Science Tracker

CNN distinguishes pancreatic cancer on contrast CT with cross-racial validation

National Taiwan University; National Taiwan University Hospital · 1 Jun 2020 · medicine

Discovery

CNN distinguishes pancreatic cancer on contrast CT with cross-racial validation

A CNN trained on contrast-enhanced CT from a Taiwanese centre reached 98.3% sensitivity on combined local test sets versus 92.9% for radiologists (difference 5.4 points, p=0.014). On a US external test set, sensitivity fell to 79.0% with specificity 97.6% (AUC 0.920), and sensitivity for tumours under 2 cm was 63.1% in that set. The study is retrospective and the authors describe it as supplementary to radiologists.

Technology: Convolutional neural network applied to CT image patches

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: A CNN trained on Taiwanese contrast CT was tested on local test sets against radiologists and on an external US test set, where it reached 79.0% sensitivity and 97.6% specificity.
  • Still unknown: The study is retrospective; sensitivity for tumours under 2 cm was 63.1% on the US set, and radiologist comparisons covered only the local sets.
  • AI role: A CNN classified image patches as cancerous and labelled each patient by the proportion of cancerous patches; the authors describe it as supplementary to radiologists.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33328124%20AND%20SRC:MED&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 233 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.